Zacks Research Issues Negative Outlook for Revvity Earnings

Revvity, Inc. (NYSE:RVTY - Free Report) - Investment analysts at Zacks Research decreased their Q2 2025 EPS estimates for Revvity in a research note issued to investors on Monday, May 19th. Zacks Research analyst R. Department now anticipates that the company will earn $1.15 per share for the quarter, down from their prior estimate of $1.24. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Zacks Research also issued estimates for Revvity's FY2025 earnings at $4.90 EPS, Q2 2026 earnings at $1.31 EPS and FY2026 earnings at $5.44 EPS.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. The business had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The company's revenue was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.98 earnings per share.

RVTY has been the subject of a number of other research reports. UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and decreased their price objective for the stock from $145.00 to $115.00 in a research report on Thursday, May 1st. Raymond James reiterated an "outperform" rating and issued a $120.00 price objective (down previously from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. Wall Street Zen cut shares of Revvity from a "buy" rating to a "hold" rating in a research note on Saturday. The Goldman Sachs Group cut their target price on shares of Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. Finally, JPMorgan Chase & Co. cut their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research note on Tuesday, April 29th. Five investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $125.64.

Revvity Price Performance

Shares of Revvity stock traded down $1.01 during trading hours on Wednesday, reaching $89.47. The stock had a trading volume of 1,023,503 shares, compared to its average volume of 950,377. The stock's 50 day moving average is $96.71 and its 200 day moving average is $109.32. The firm has a market capitalization of $10.55 billion, a PE ratio of 40.48, a PEG ratio of 3.82 and a beta of 1.02. Revvity has a twelve month low of $88.01 and a twelve month high of $129.50. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.31%. Revvity's dividend payout ratio is presently 11.91%.

Institutional Trading of Revvity

Several large investors have recently bought and sold shares of the business. HB Wealth Management LLC boosted its holdings in Revvity by 4.6% in the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company's stock valued at $266,000 after purchasing an additional 104 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its holdings in Revvity by 55.9% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock valued at $43,000 after purchasing an additional 138 shares during the last quarter. Atomi Financial Group Inc. boosted its holdings in Revvity by 8.8% in the 4th quarter. Atomi Financial Group Inc. now owns 1,861 shares of the company's stock valued at $208,000 after purchasing an additional 151 shares during the last quarter. Westside Investment Management Inc. boosted its holdings in Revvity by 0.8% in the 4th quarter. Westside Investment Management Inc. now owns 14,363 shares of the company's stock valued at $1,603,000 after purchasing an additional 108 shares during the last quarter. Finally, Janney Montgomery Scott LLC boosted its holdings in Revvity by 87.0% in the 4th quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock valued at $881,000 after purchasing an additional 3,672 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company's stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.